# A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

> **NCT06490445** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Syqe Medical** · enrollment: 122 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Medical Cannabis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06490445
- **Lead sponsor:** Syqe Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2026-06-20
- **Final completion:** 2026-07-20
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490445, "A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06490445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*